NasdaqGM - Delayed Quote USD
Trevi Therapeutics, Inc. (TRVI)
6.32
-0.20
(-3.00%)
At close: June 2 at 4:00:00 PM EDT
6.12
-0.19
(-3.09%)
After hours: June 2 at 6:55:17 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.1 | -0.11 | -0.44 | -0.5 |
| Low Estimate | -0.12 | -0.15 | -0.51 | -0.66 |
| High Estimate | -0.09 | -0.09 | -0.38 | -0.26 |
| Year Ago EPS | -0.12 | -0.13 | -0.47 | -0.44 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.11 | -0.11 | -0.12 | -0.12 |
| EPS Actual | -0.12 | -0.13 | -0.11 | -0.09 |
| Difference | -0.01 | -0.02 | 0.01 | 0.03 |
| Surprise % | -11.11% | -15.19% | 7.04% | 26.03% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.11 | -0.44 | -0.5 |
| 7 Days Ago | -0.1 | -0.11 | -0.44 | -0.51 |
| 30 Days Ago | -0.13 | -0.14 | -0.54 | -0.58 |
| 60 Days Ago | -0.13 | -0.14 | -0.54 | -0.58 |
| 90 Days Ago | -0.13 | -0.14 | -0.5 | -0.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 4 | 6 | 5 |
| Up Last 30 Days | 5 | 4 | 6 | 5 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TRVI | 15.28% | 14.10% | 7.09% | -15.27% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 6/2/2025 |
| Initiated | HC Wainwright & Co.: Buy | 5/28/2025 |
| Reiterates | Needham: Buy to Buy | 5/20/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | B. Riley Securities: Buy to Buy | 3/19/2025 |
| Maintains | Needham: Buy to Buy | 3/19/2025 |
Related Tickers
COGT Cogent Biosciences, Inc.
5.61
+3.13%
LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
VRDN Viridian Therapeutics, Inc.
13.97
+0.36%
MLYS Mineralys Therapeutics, Inc.
15.70
+0.77%
FULC Fulcrum Therapeutics, Inc.
6.96
+1.24%
ORKA Oruka Therapeutics, Inc.
11.77
+7.39%
EWTX Edgewise Therapeutics, Inc.
14.69
+2.87%
VYNE VYNE Therapeutics Inc.
0.9280
-2.32%
STOK Stoke Therapeutics, Inc.
9.91
+3.88%
MREO Mereo BioPharma Group plc
2.5500
+18.60%